Healthcare provider profile · identity verified

Timothy Wayne Mummert, D.O.

Internal Medicine · PORT CLINTON, OH · NPI 1265426993

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	705	201
Lisinopril	Lisinopril	422	111
Losartan Potassium	Losartan Potassium	382	109
Levothyroxine Sodium	Levothyroxine Sodium	286	74
Omeprazole	Omeprazole	285	92
Metoprolol Succinate	Metoprolol Succinate	267	76
Amlodipine Besylate	Amlodipine Besylate	247	74
Albuterol Sulfate Hfa	Albuterol Sulfate	202	50
Rosuvastatin Calcium	Rosuvastatin Calcium	198	62
Hydrochlorothiazide	Hydrochlorothiazide	195	51
Metformin Hcl	Metformin Hcl	182	52
Furosemide	Furosemide	179	47
Potassium Chloride	Potassium Chloride	167	51
Gabapentin	Gabapentin	165	37
Metoprolol Tartrate	Metoprolol Tartrate	162	41
Tamsulosin Hcl	Tamsulosin Hcl	146	45
Simvastatin	Simvastatin	143	32
Sertraline Hcl	Sertraline Hcl	139	36
Pantoprazole Sodium	Pantoprazole Sodium	116	32
Allopurinol	Allopurinol	107	28
Tizanidine Hcl	Tizanidine Hcl	105	29
Fluticasone Propionate	Fluticasone Propionate	99	42
Montelukast Sodium	Montelukast Sodium	97	25
Duloxetine Hcl	Duloxetine Hcl	96	23
Synthroid	Levothyroxine Sodium	95	25
Pravastatin Sodium	Pravastatin Sodium	93	24
Ozempic	Semaglutide	88	20
Pioglitazone Hcl	Pioglitazone Hcl	87	30
Carvedilol	Carvedilol	84	26
Spironolactone	Spironolactone	81	29
Eliquis	Apixaban	79	24
Trazodone Hcl	Trazodone Hcl	79	29
Prednisone	Prednisone	76	41
Clopidogrel	Clopidogrel Bisulfate	74	23
Jardiance	Empagliflozin	74	16
Alendronate Sodium	Alendronate Sodium	72	22
Trulicity	Dulaglutide	70	21
Tramadol Hcl	Tramadol Hcl	67	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	67	12
Famotidine	Famotidine	63	17
Ezetimibe	Ezetimibe	62	19
Glimepiride	Glimepiride	62	17
Meloxicam	Meloxicam	58	17
Januvia	Sitagliptin Phosphate	57	13
Alprazolam	Alprazolam	56	suppressed
Pregabalin	Pregabalin	56	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	54	suppressed
Citalopram Hbr	Citalopram Hydrobromide	53	15
Clonazepam	Clonazepam	47	suppressed
Atenolol	Atenolol	46	13
Metformin Hcl Er	Metformin Hcl	45	suppressed
Buspirone Hcl	Buspirone Hcl	43	14
Ropinirole Hcl	Ropinirole Hcl	41	suppressed
Warfarin Sodium	Warfarin Sodium	41	11
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Lorazepam	Lorazepam	40	suppressed
Xarelto	Rivaroxaban	40	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	38	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	14
Farxiga	Dapagliflozin Propanediol	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	12
Valsartan	Valsartan	34	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	suppressed
Bupropion Hcl	Bupropion Hcl	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	20
Aripiprazole	Aripiprazole	29	suppressed
Nystatin	Nystatin	29	14
Nifedipine Er	Nifedipine	28	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Azithromycin	Azithromycin	27	22
Verapamil Er	Verapamil Hcl	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	25	25
Chlorthalidone	Chlorthalidone	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Klor-Con M20	Potassium Chloride	25	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	19
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	17
Telmisartan	Telmisartan	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Finasteride	Finasteride	19	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Risperidone	Risperidone	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Breyna	Budesonide/Formoterol Fumarate	17	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	16	14
Irbesartan	Irbesartan	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Premarin	Estrogens, Conjugated	14	suppressed
Baclofen	Baclofen	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Ramipril	Ramipril	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Topiramate	Topiramate	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error